Response to BDD was wild, response to upcoming IDE submission was muted and almost non-existent for more than a month. Price of 0.05 to 0.06 in Feb when we KNEW that IDE would be submitted in a few months was super crazy. Since then price has been climbing at a relatively stable rate without giant jumps. Even now with a market cap $70 million it is underpriced.
This a product that is not only a Brachytherapy device, but can also be used in place of surgery to treat almost any solid tumor. Not only treat them but treat them more effectively and with fewer side effects. That is a billion dollar market!!
Top that off with that it has been used in animals for years without a single negative impact or unexpected result.